.Pharmacolibrary.Drugs.ATC.N.N02AX06 .Pharmacolibrary.Drugs.ATC.N.N02AX06| name: | Tapentadol |
| ATC code: | N02AX06 | route: | oral |
| n-compartments | 1 |
Tapentadol is a centrally acting opioid analgesic used for the management of moderate to severe acute pain and chronic pain. It is a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor. Tapentadol is approved and in use today for pain management in various countries.
Pharmacokinetic parameters as reported in healthy adult volunteers following oral immediate-release tapentadol.
Khalil, F, et al., & Freijer, J (2020). Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old. Journal of pain research 13 3107–3123. DOI:10.2147/JPR.S269549 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33262645
Jończyk, R, et al., & Khalil, F (2022). Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years. Journal of pain research 15 3103–3114. DOI:10.2147/JPR.S364902 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36203787
Xu, XS, et al., & Nandy, P (2010). Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain. Clinical pharmacokinetics 49(10) 671–682. DOI:10.2165/11535390-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20818833